Plain-English translation of NCT06864234 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Researchers are testing metoprolol, a medication commonly used to treat heart conditions, to see how it affects blood flow in the small blood vessels of the heart. Some patients experience chest pain even though their main heart arteries look normal on imaging—this study aims to understand whether this medication can help improve blood flow in these tiny vessels and reduce symptoms.
Recent studies have shown that many patients with normal-looking coronary arteries still have problems with blood flow in their smallest heart blood vessels. Treatment guidelines now recommend this medication for these patients, but doctors don't fully understand how it works or how well it truly improves blood flow—this study aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive either the study medication or a placebo (salt water) as a small injection during your heart catheterization procedure. The research team will then measure how your blood vessels respond and compare the effects of the medication versus placebo. Your participation involves this single injection during a procedure you are already undergoing for diagnostic purposes.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Belgium